Document is current
Any future updates will be listed below
-
Authors
Lafuente-Lafuente, Carmelo https://orcid.org/0000-0002-2475-4670
Candia, Evany Heinichen
Pautas, Eric https://orcid.org/0000-0001-6717-7589
Freund, Yonathan https://orcid.org/0000-0002-0262-3848
Oquendo, Bruno
Belmin, Joël https://orcid.org/0000-0003-1630-9582
,
Arfaoui, Laura
Boddaert, Jacques
Delannoy, Quentin
Kacher, Zineb
Oasi, Christel
Paillaud, Elena
Pariel, Sylvie
Verny, Marc
-
Funding
Funding for this research was provided by:
Sorbonne Université
Assistance Publique - Hôpitaux de Paris
Université Paris-Est Créteil
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 11 March 2025
First Online: 20 April 2025
Declarations
:
: Dr Lafuente-Lafuente received honoraria for lectures from Boheringer, support for attending meetings from Pfizer. Pr Belmin received honoraria for lectures and participation on advisory boards from Pfizer, Boehringer Ingelheim, Novartis and Janssen. Dr Evany Candia, Dr Oquendo, Pr Freund, Pr Pautas have no relevant financial or non-financial interests to disclose.
: The pilot study was approved by the corresponding regional ethics committee (Comité de Protection de Personnes d’Île-de-France II, study number 21.00279.000003 RIPH3 HPS).
: Informed consent was obtained from all participants included.
